Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

• Status: Completed
• Trial end date: 2015-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This trial is testing the safety of combining the oral chemotherapy drug capecitabine with radio-labeled microspheres injected directly into the liver.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fox Chase Cancer Center
• Collaborator: Sirtex Medical
• Treatments: Capecitabine

Criteria

Inclusion Criteria:

• Adequate liver function

• Adequate performance status

Exclusion Criteria:

• Significant extrahepatic disease